Joung-Soon Jang

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

Choong‐kun Lee, Hong Jae Chon, Jaekyung Cheon et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 124 citations · Full text

Medicine, Oncology, Pharmacology +12

Combination Chemotherapy With Gemcitabine and Cisplatin as First-Line Treatment for Immunohistochemically Proven Cholangiocarcinoma

Gyeong‐Won Lee, Jung Hun Kang, Hun-Gu Kim et al. · American Journal of Clinical Oncology · 2006 · 68 citations

Medicine, Oncology, Pharmacology +15

Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy

Song Ee Park, In Gyu Hwang, Chang Hwan Choi et al. · Medicine · 2018 · 50 citations · Full text

Medicine, Oncology, Surgery +15

Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients

In Gyu Hwang, Joung-Soon Jang, Jesselina Francisco dos Santos H. et al. · Cancer Chemotherapy and Pharmacology · 2011 · 27 citations

Medicine, Cancer Biology, Oncology +9

The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas

Young Saing Kim, Sung Yong Oh, Se‐Il Go et al. · Cancer Chemotherapy and Pharmacology · 2016 · 21 citations

Medicine, Oncology, Surgery +16